Scarica l'app Stockscreener
34.66
2.33%
0.7897
Precedente Chiudi:
$33.87
Aprire:
$34.275
Volume 24 ore:
18,634
Relative Volume:
1.30
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.45%
1M Prestazione:
+6.53%
6M Prestazione:
+33.24%
1 anno Prestazione:
+37.58%
Intervallo 1D:
$34.27
$34.73
Intervallo di 1 settimana:
$33.51
$34.88
Portata 52W:
$20.01
$34.93
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Nome
Roundhill Glp 1 Weight Loss Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta OZEM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
34.64 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.45 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
680.84 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.86 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
262.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
617.06 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Borsa (OZEM) Ultime notizie
6 Top-Performing ETF Areas of Last Week - The Globe and Mail
(OZEM) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Can You Buy Ozempic Stock in 2025? - The Motley Fool
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
N-PX: Others - 富途牛牛
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - Yahoo Finance
OZEMRoundhill GLP-1 & Weight Loss ETF Latest Stock News & Market Updates - Stock Titan
Roundhill GLP-1 & Weight Loss ETF Review and Aggregate Rating (OZEM) - MarketBeat
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)Dividends - intelligentinvestor.com.au
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
Roundhill GLP-1 & Weight Loss ETF (OZEM) Institutional Ownership 2025 - MarketBeat
Roundhill GLP-1 & Weight Loss ETF (OZEM) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
OZEM Financial Statements & ChartsRoundhill Etf TrustRoundhill Glp-1 & Weight Loss Etf MacroTrends - CMLviz
Roundhill Glp-1 & Weight Loss ETF (OZEM) Holdings - Yahoo! Finance Canada
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Roundhill Glp-1 & Weight Loss ETF (OZEM) holdings - Yahoo Finance UK
The FSA Spy market buzz – 31 May 2024 - Fund Selector Asia
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - Sahm
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
OZEM: ROUNDHILL GLP-1 & WEIGHT LOSS ETFFund Chart - Zacks Investment Research
Roundhill ETF TrustRoundhill GLP-1 & Weight Loss ETF - CMLviz
Roundhill Glp 1 Weight Loss Etf Azioni (OZEM) Dati Finanziari
Non sono disponibili dati finanziari per Roundhill Glp 1 Weight Loss Etf (OZEM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.61%
Capitalizzazione:
|
Volume (24 ore):